 |
decitabine |
|---|---|
| Trade Name | |
| Orphan Indication | Sickle cell anemia |
| USA Market Approval | USA |
| USA Designation Date | 2002-09-09 00:00:00 |
| Sponsor | Otsuka Pharmaceutical Development &;Commercialization, Inc., 508 Carnegie Center Drive;Princeton, New Jersey, 08540 |
Related Access Program